Choudhari Drug Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.60 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth -65.53%
- Profit Growth -266.32%
- Ebitda -1653.45%
- Net Worth -540.83%
- Total Assets -24.85%
About Choudhari Drug Distributors
Choudhari Drug Distributors Private Limited (CDDPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2011 and has a history of 13 years and one month. Its registered office is in Belgaum, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.60 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Poonam Choudhari and Rajendra Choudhari serve as directors at the Company.
Company Details
-
Location
Belgaum, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24132KA2011PTC061675
-
Company No.
061675
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Dec 2011
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Choudhari Drug Distributors?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Choudhari
|
Director | 15-Dec-2011 | Current |
|
Rajendra Choudhari
|
Director | 15-Dec-2011 | Current |
Financial Performance of Choudhari Drug Distributors.
Choudhari Drug Distributors Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 65.53% decrease. The company also saw a substantial fall in profitability, with a 266.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 540.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Choudhari Drug Distributors?
In 2021, Choudhari Drug Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹20.00 M
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
- Cosmos Co-Operative Bank Ltd : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Others | ₹1.50 Cr | Satisfied |
| 09 Jun 2012 | Cosmos Co-Operative Bank Ltd | ₹5.00 M | Satisfied |
How Many Employees Work at Choudhari Drug Distributors?
Unlock and access historical data on people associated with Choudhari Drug Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Choudhari Drug Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Choudhari Drug Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
